QuestionAugust 21, 2025

A client reports using an imported herbal capsule with no labeling in English. Which DSHEA-related risks should the nurse evaluate? (Select all that apply.) A Potential for unlabeled active ingredients B Regulatory oversight of foreign manufacturers C Client belief that importation ensures higher quality D FDA enforcement limitations on non-U.5, products E Misuse due to lack of dosing instructions

A client reports using an imported herbal capsule with no labeling in English. Which DSHEA-related risks should the nurse evaluate? (Select all that apply.) A Potential for unlabeled active ingredients B Regulatory oversight of foreign manufacturers C Client belief that importation ensures higher quality D FDA enforcement limitations on non-U.5, products E Misuse due to lack of dosing instructions
A client reports using an imported herbal capsule with no labeling in English. Which DSHEA-related risks should the nurse
evaluate? (Select all that apply.)
A Potential for unlabeled active ingredients
B Regulatory oversight of foreign manufacturers
C Client belief that importation ensures higher quality
D FDA enforcement limitations on non-U.5, products
E Misuse due to lack of dosing instructions

Solution
4.6(315 votes)

Answer

A, B, C, D, E Explanation 1. Identify DSHEA-related risks Evaluate the potential for unlabeled active ingredients, as DSHEA does not require pre-market approval for dietary supplements. 2. Consider regulatory oversight Assess the regulatory oversight of foreign manufacturers, which may differ from U.S. standards under DSHEA. 3. Examine client beliefs Consider the client's belief that importation ensures higher quality, which can be misleading and risky. 4. Review FDA enforcement limitations Recognize FDA enforcement limitations on non-U.S. products, as DSHEA primarily governs domestic products. 5. Address misuse concerns Evaluate the risk of misuse due to lack of dosing instructions, a common issue with unlabeled or foreign products.

Explanation

1. Identify DSHEA-related risks<br /> Evaluate the potential for unlabeled active ingredients, as DSHEA does not require pre-market approval for dietary supplements.<br /><br />2. Consider regulatory oversight<br /> Assess the regulatory oversight of foreign manufacturers, which may differ from U.S. standards under DSHEA.<br /><br />3. Examine client beliefs<br /> Consider the client's belief that importation ensures higher quality, which can be misleading and risky.<br /><br />4. Review FDA enforcement limitations<br /> Recognize FDA enforcement limitations on non-U.S. products, as DSHEA primarily governs domestic products.<br /><br />5. Address misuse concerns<br /> Evaluate the risk of misuse due to lack of dosing instructions, a common issue with unlabeled or foreign products.
Click to rate:

Similar Questions